Table 1.
Characteristics of the study cohort and the concurrent subsample
| Study Cohort (N = 253,684) |
Concurrent subsample (N = 333) |
|
|---|---|---|
| Age (years) | 76.3 (7.9) | 79.9 (5.9) |
| Gender: female | 59.5% | 57.7% |
| eFRAGICAP score | ||
| Mean (SD) | 0.17 (0.12) | 0.26 (0.12) |
| Median (IQR) | 0.14 (0.08–0.25) | 0.25 (0.18–0.33) |
| 99th percentile | 0.52 | 0.60 |
| Males | 0.16 (0.11) | 0.25 (0.10) |
| Females | 0.18 (0.12) | 0.27 (0.13) |
| Frailty categories | ||
| Fit | 41.1% | 12.6% |
| Mild | 32.2% | 31.5% |
| Moderate | 18.7% | 39.6% |
| Severe | 7.9% | 16.2% |
| Number of comorbidities (*) | 2.03 (1.28) | 2.70 (1.20) |
| Number of medications | 5.51 (4.0) | 8.26 (3.90) |
| Social deprivation | ||
| 1 (least deprivation) | 36.9% | 0% |
| 2 | 32.0% | 87.1% |
| 3 | 5.3% | 0.6% |
| 4 | 10.6% | 9.3% |
| 5 (most deprived) | 15.3% | 3.0% |
| CFS > 4 | 19.2% | |
| RISC level medium high | 23.7% | |
Note: Numeric variables are described as mean (standard deviation) unless otherwise stated. Categorical variables are presented as percentages. (*) out of a list of conditions including cardiovascular disease, cancer, asthma, COPD, diabetes, psychiatric disorders, Parkinson disease, arthritis, and osteoporosis